A new study of Dirk Schmidt-Arras and colleagues from the Tumor Immunology group identified the membrane-bound metalloprotease ADAM17 as novel drug target for inhibiting the metastatic spread of cancer cells. The paper has recently been published in the prestigious Journal of Experimental Medicine. To access the full paper visit:  https://rupress.org/…/Inhibition-of-ADAM17-impairs…

Congratulations for this intriguing work!